Liraglutide vs Semaglutide: C16 palmitate vs C18 diacid, and the published half-life that follows

Same backbone, same receptor, different fatty acid. That single structural decision drives the entire published-half-life difference between them. It is the cleanest example of how a small chemistry choice produces a large research-outcome change.

Identity at a glance

Liraglutide is a 31-residue GLP-1 analogue with a C16 palmitate fatty-acid modification, MW ≈ 3,751 Da. Semaglutide is a 31-residue GLP-1 analogue with a C18 diacid plus an Aib substitution at position 2, MW ≈ 4,113 Da. Same length, different lipid chemistry, different albumin-binding behaviour.

Treat each SKU as a separate line on the CoA review even when they ship in the same procurement cycle. Sequence, modification and molecular weight are the fields that decide whether your protocol is reproducible.

Mechanism and research framing

Both engage GLP-1R selectively. The published half-life difference is driven by albumin-binding affinity (stronger for Semaglutide due to C18 diacid) and DPP-IV resistance (improved for Semaglutide due to the Aib substitution). In comparative cellular research, free-fraction calculations matter more than nominal concentration.

Cite the literature each reference actually lives in, rather than transferring assumptions from the adjacent material. Matched buffers, matched controls and matched concentration ranges are the floor for comparative work.

Storage, stability and lab handling

Both lyophilised, both store cold and dry. In reconstituted form, Semaglutide tolerates extended storage marginally better in matched conditions, but neither should be left at room temperature for working assays. Record free fraction (BSA-corrected) rather than just nominal concentration when comparing them.

Aliquot before first freeze, label with lot and reconstitution date, and document freeze-thaw count per vial. Stability assumptions do not transfer between adjacent references even when the storage temperature does.

Next steps for procurement and the lab bench

If you are stocking Liraglutide and Semaglutide for parallel work, build the CoA package, the storage SOP and the reconstitution log before the order ships rather than after.

Pair this comparison with each product page, the matching product research guide, the storage guide and the CoA review guide. The internal links below route directly into those resources.

Document reviewers should cross-link this guide with the product certificate of analysis and internal receiving SOP.

When publishing methods, cite lot number, SKU, reconstitution buffer, and stock concentration so external labs can interpret your figures.

Institutional procurement may require RUO acknowledgment at checkout; store that acknowledgment beside batch records for audits.

If assay results drift across quarters, compare storage logs and CoA revision before questioning sequence integrity.

Third-party summaries, when available, should be filed as supplements—not replacements—for CoA identity data.

Document reviewers should cross-link this guide with the product certificate of analysis and internal receiving SOP.

When publishing methods, cite lot number, SKU, reconstitution buffer, and stock concentration so external labs can interpret your figures.

Institutional procurement may require RUO acknowledgment at checkout; store that acknowledgment beside batch records for audits.

If assay results drift across quarters, compare storage logs and CoA revision before questioning sequence integrity.

Third-party summaries, when available, should be filed as supplements—not replacements—for CoA identity data.

Document reviewers should cross-link this guide with the product certificate of analysis and internal receiving SOP.

When publishing methods, cite lot number, SKU, reconstitution buffer, and stock concentration so external labs can interpret your figures.

Institutional procurement may require RUO acknowledgment at checkout; store that acknowledgment beside batch records for audits.

If assay results drift across quarters, compare storage logs and CoA revision before questioning sequence integrity.

Third-party summaries, when available, should be filed as supplements—not replacements—for CoA identity data.

Document reviewers should cross-link this guide with the product certificate of analysis and internal receiving SOP.

When publishing methods, cite lot number, SKU, reconstitution buffer, and stock concentration so external labs can interpret your figures.

Institutional procurement may require RUO acknowledgment at checkout; store that acknowledgment beside batch records for audits.

If assay results drift across quarters, compare storage logs and CoA revision before questioning sequence integrity.

Third-party summaries, when available, should be filed as supplements—not replacements—for CoA identity data.

Document reviewers should cross-link this guide with the product certificate of analysis and internal receiving SOP.

When publishing methods, cite lot number, SKU, reconstitution buffer, and stock concentration so external labs can interpret your figures.

Institutional procurement may require RUO acknowledgment at checkout; store that acknowledgment beside batch records for audits.

If assay results drift across quarters, compare storage logs and CoA revision before questioning sequence integrity.

Third-party summaries, when available, should be filed as supplements—not replacements—for CoA identity data.

Document reviewers should cross-link this guide with the product certificate of analysis and internal receiving SOP.

When publishing methods, cite lot number, SKU, reconstitution buffer, and stock concentration so external labs can interpret your figures.

Institutional procurement may require RUO acknowledgment at checkout; store that acknowledgment beside batch records for audits.

If assay results drift across quarters, compare storage logs and CoA revision before questioning sequence integrity.

Third-party summaries, when available, should be filed as supplements—not replacements—for CoA identity data.

Document reviewers should cross-link this guide with the product certificate of analysis and internal receiving SOP.

When publishing methods, cite lot number, SKU, reconstitution buffer, and stock concentration so external labs can interpret your figures.

Institutional procurement may require RUO acknowledgment at checkout; store that acknowledgment beside batch records for audits.

If assay results drift across quarters, compare storage logs and CoA revision before questioning sequence integrity.

Third-party summaries, when available, should be filed as supplements—not replacements—for CoA identity data.

Document reviewers should cross-link this guide with the product certificate of analysis and internal receiving SOP.

When publishing methods, cite lot number, SKU, reconstitution buffer, and stock concentration so external labs can interpret your figures.

Institutional procurement may require RUO acknowledgment at checkout; store that acknowledgment beside batch records for audits.

If assay results drift across quarters, compare storage logs and CoA revision before questioning sequence integrity.

Third-party summaries, when available, should be filed as supplements—not replacements—for CoA identity data.